Maria Cláudia Nascimento

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study

Jean van Wyk, Faïza Ajana, Fiona Bisshop et al. · Clinical Infectious Diseases · 2020 · 257 citations · Full text

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

Michael Aboud, Richard Kaplan, Johannes Lombaard et al. · The Lancet Infectious Diseases · 2019 · 190 citations

First-line Therapy, Human Retrovirus, Immunology +9

Prevalence of hepatitis B and C serological markers among first‐time blood donors in Brazil: A multi‐center serosurvey

Maria Cláudia Nascimento, Philippe Mayaud, Éster Cerdeira Sabino et al. · Journal of Medical Virology · 2007 · 71 citations · Full text

Comparative Study of Kaposi's Sarcoma-Associated Herpesvirus Serological Assays Using Clinically and Serologically Defined Reference Standards and Latent Class Analysis

Maria Cláudia Nascimento, Vanda Akico de Souza, Laura Masami Sumita et al. · Journal of Clinical Microbiology · 2006 · 48 citations · Full text

Vaccination, Diagnostic Virology, Imt Whole-virus Elisa +14

Performance of the HerpeSelect (Focus) and Kalon Enzyme-Linked Immunosorbent Assays for Detection of Antibodies against Herpes Simplex Virus Type 2 by Use of Monoclonal Antibody-Blocking Enzyme Immunoassay and Clinicovirological Reference Standards in Brazil

Maria Cláudia Nascimento, Suzete C. Ferreira, Éster Cerdeira Sabino et al. · Journal of Clinical Microbiology · 2007 · 22 citations · Full text

Vaccination, Diagnostic Virology, Allergy +13